EverSource Wealth Advisors’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$668	Buy	50 +40	+400%	+$534	﹤0.01%	3818
2025 Q1	$102	Buy	+10	New	+$102	﹤0.01%	3826